Physician profile
Deepu Alexander
NPI 1275728560
$1,929.07
in general payments reported to CMS, 2019-2025
19 companies · $383 in 2025
The $383 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2020: $83.88 · 2021: $486 · 2022: $482 · 2023: $167 · 2024: $88.66 · 2025: $383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $638.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $499.91 | 2019-2025 | Aveir |
| Novartis Pharmaceuticals Corporation | $396.89 | 2019-2025 | |
| Boston Scientific Corporation | $147.00 | 2019-2023 | Varithena Administration Pack |
| Angiodynamics, INC. | $133.56 | 2022 | |
| Novo Nordisk INC | $115.96 | 2023-2025 | Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $90.85 | 2019-2022 | |
| Tactile Systems Technology INC | $89.03 | 2023-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Pfizer INC. | $89.02 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $69.75 | 2020-2023 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $64.54 | 2021-2025 | Camzyos, Eliquis |
| Medtronic, INC. | $60.07 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.75 | 2022 | |
| Amgen INC. | $24.86 | 2024 | Repatha |
| Regeneron Healthcare Solutions, INC. | $24.13 | 2019 | |
| Corcept Therapeutics | $20.99 | 2025 | Korlym |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $20.74 | 2025 | |
| Esperion Therapeutics, INC. | $19.02 | 2021 | |
| Sanofi-Aventis U.S. LLC | $15.44 | 2022 | |
| Cook Medical LLC | $13.56 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepu Alexander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.